METTLER-TOLEDO INTERNATIONAL (MTD) Stock Fundamental Analysis
NYSE:MTD - New York Stock Exchange, Inc. - US5926881054 - Common Stock - Currency: USD
MTD gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 54 industry peers in the Life Sciences Tools & Services industry. While MTD belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. MTD is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
MTD had positive earnings in the past year.
MTD had a positive operating cash flow in the past year.
Each year in the past 5 years MTD has been profitable.
MTD had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
MTD's Return On Assets of 24.40% is amongst the best of the industry. MTD outperforms 98.15% of its industry peers.
MTD has a Return On Invested Capital of 39.61%. This is amongst the best in the industry. MTD outperforms 96.30% of its industry peers.
The Average Return On Invested Capital over the past 3 years for MTD is significantly above the industry average of 16.00%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 24.4% | ||
| ROE | N/A | ||
| ROIC | 39.61% |
ROA(3y)25.04%
ROA(5y)23.93%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)41.86%
ROIC(5y)39.3%
1.3 Margins
MTD has a Profit Margin of 21.46%. This is amongst the best in the industry. MTD outperforms 98.15% of its industry peers.
MTD's Profit Margin has improved in the last couple of years.
The Operating Margin of MTD (28.61%) is better than 100.00% of its industry peers.
In the last couple of years the Operating Margin of MTD has grown nicely.
MTD has a better Gross Margin (59.94%) than 81.48% of its industry peers.
In the last couple of years the Gross Margin of MTD has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 28.61% | ||
| PM (TTM) | 21.46% | ||
| GM | 59.94% |
OM growth 3Y2.77%
OM growth 5Y3.56%
PM growth 3Y2.52%
PM growth 5Y3.63%
GM growth 3Y0.93%
GM growth 5Y0.74%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so MTD is creating value.
Compared to 1 year ago, MTD has less shares outstanding
MTD has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, MTD has a worse debt to assets ratio.
2.2 Solvency
MTD has an Altman-Z score of 10.02. This indicates that MTD is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 10.02, MTD belongs to the best of the industry, outperforming 94.44% of the companies in the same industry.
MTD has a debt to FCF ratio of 2.58. This is a good value and a sign of high solvency as MTD would need 2.58 years to pay back of all of its debts.
MTD has a better Debt to FCF ratio (2.58) than 79.63% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 2.58 | ||
| Altman-Z | 10.02 |
ROIC/WACC3.91
WACC10.12%
2.3 Liquidity
A Current Ratio of 1.12 indicates that MTD should not have too much problems paying its short term obligations.
With a Current ratio value of 1.12, MTD is not doing good in the industry: 83.33% of the companies in the same industry are doing better.
MTD has a Quick Ratio of 1.12. This is a bad value and indicates that MTD is not financially healthy enough and could expect problems in meeting its short term obligations.
MTD has a Quick ratio of 0.77. This is amonst the worse of the industry: MTD underperforms 87.04% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.12 | ||
| Quick Ratio | 0.77 |
3. Growth
3.1 Past
MTD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.37%, which is quite good.
MTD shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 12.53% yearly.
Looking at the last year, MTD shows a small growth in Revenue. The Revenue has grown by 3.10% in the last year.
MTD shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.18% yearly.
EPS 1Y (TTM)8.37%
EPS 3Y6.67%
EPS 5Y12.53%
EPS Q2Q%4.56%
Revenue 1Y (TTM)3.1%
Revenue growth 3Y1.37%
Revenue growth 5Y5.18%
Sales Q2Q%3.85%
3.2 Future
MTD is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.32% yearly.
The Revenue is expected to grow by 3.81% on average over the next years.
EPS Next Y2.01%
EPS Next 2Y6.19%
EPS Next 3Y7.97%
EPS Next 5Y9.32%
Revenue Next Year2.3%
Revenue Next 2Y3.44%
Revenue Next 3Y4.02%
Revenue Next 5Y3.81%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 30.24, the valuation of MTD can be described as expensive.
Based on the Price/Earnings ratio, MTD is valued a bit cheaper than 66.67% of the companies in the same industry.
When comparing the Price/Earnings ratio of MTD to the average of the S&P500 Index (26.54), we can say MTD is valued inline with the index average.
Based on the Price/Forward Earnings ratio of 26.65, the valuation of MTD can be described as expensive.
MTD's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. MTD is cheaper than 70.37% of the companies in the same industry.
MTD's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 35.28.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 30.24 | ||
| Fwd PE | 26.65 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, MTD is valued a bit cheaper than 68.52% of the companies in the same industry.
62.96% of the companies in the same industry are more expensive than MTD, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 30.32 | ||
| EV/EBITDA | 22.4 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates MTD does not grow enough to justify the current Price/Earnings ratio.
MTD has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)15.04
PEG (5Y)2.41
EPS Next 2Y6.19%
EPS Next 3Y7.97%
5. Dividend
5.1 Amount
MTD does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
1236.96
+15.12 (+1.24%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners101.55%
Inst Owner Change-1.15%
Ins Owners0.42%
Ins Owner Change1.1%
Market Cap25.70B
Analysts71.58
Price Target1311.82 (6.05%)
Short Float %3.07%
Short Ratio3.64
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.38%
Min EPS beat(2)2.78%
Max EPS beat(2)3.98%
EPS beat(4)4
Avg EPS beat(4)3.18%
Min EPS beat(4)1.02%
Max EPS beat(4)4.94%
EPS beat(8)6
Avg EPS beat(8)3.16%
EPS beat(12)10
Avg EPS beat(12)2.65%
EPS beat(16)14
Avg EPS beat(16)3.36%
Revenue beat(2)1
Avg Revenue beat(2)0.73%
Min Revenue beat(2)-0.18%
Max Revenue beat(2)1.63%
Revenue beat(4)3
Avg Revenue beat(4)1.01%
Min Revenue beat(4)-0.18%
Max Revenue beat(4)2.56%
Revenue beat(8)5
Avg Revenue beat(8)0.5%
Revenue beat(12)8
Avg Revenue beat(12)0.25%
Revenue beat(16)12
Avg Revenue beat(16)0.61%
PT rev (1m)1.51%
PT rev (3m)-3.06%
EPS NQ rev (1m)0.41%
EPS NQ rev (3m)-5.94%
EPS NY rev (1m)0.15%
EPS NY rev (3m)-2.65%
Revenue NQ rev (1m)0.03%
Revenue NQ rev (3m)-0.35%
Revenue NY rev (1m)0.1%
Revenue NY rev (3m)0.13%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 30.24 | ||
| Fwd PE | 26.65 | ||
| P/S | 6.65 | ||
| P/FCF | 30.32 | ||
| P/OCF | 27.01 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 22.4 |
EPS(TTM)40.9
EY3.31%
EPS(NY)46.42
Fwd EY3.75%
FCF(TTM)40.8
FCFY3.3%
OCF(TTM)45.8
OCFY3.7%
SpS186.07
BVpS-12.45
TBVpS-57.58
PEG (NY)15.04
PEG (5Y)2.41
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 24.4% | ||
| ROE | N/A | ||
| ROCE | 48.24% | ||
| ROIC | 39.61% | ||
| ROICexc | 40.71% | ||
| ROICexgc | 70.2% | ||
| OM | 28.61% | ||
| PM (TTM) | 21.46% | ||
| GM | 59.94% | ||
| FCFM | 21.93% |
ROA(3y)25.04%
ROA(5y)23.93%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)41.86%
ROIC(5y)39.3%
ROICexc(3y)43.32%
ROICexc(5y)40.86%
ROICexgc(3y)78.59%
ROICexgc(5y)73.33%
ROCE(3y)50.98%
ROCE(5y)47.86%
ROICexcg growth 3Y5.41%
ROICexcg growth 5Y8.89%
ROICexc growth 3Y5.36%
ROICexc growth 5Y6.84%
OM growth 3Y2.77%
OM growth 5Y3.56%
PM growth 3Y2.52%
PM growth 5Y3.63%
GM growth 3Y0.93%
GM growth 5Y0.74%
F-Score7
Asset Turnover1.14
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 2.58 | ||
| Debt/EBITDA | 1.73 | ||
| Cap/Depr | 85.07% | ||
| Cap/Sales | 2.69% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 77.47% | ||
| Profit Quality | 102.18% | ||
| Current Ratio | 1.12 | ||
| Quick Ratio | 0.77 | ||
| Altman-Z | 10.02 |
F-Score7
WACC10.12%
ROIC/WACC3.91
Cap/Depr(3y)92.83%
Cap/Depr(5y)94.35%
Cap/Sales(3y)2.85%
Cap/Sales(5y)2.89%
Profit Quality(3y)97.94%
Profit Quality(5y)100.58%
High Growth Momentum
Growth
EPS 1Y (TTM)8.37%
EPS 3Y6.67%
EPS 5Y12.53%
EPS Q2Q%4.56%
EPS Next Y2.01%
EPS Next 2Y6.19%
EPS Next 3Y7.97%
EPS Next 5Y9.32%
Revenue 1Y (TTM)3.1%
Revenue growth 3Y1.37%
Revenue growth 5Y5.18%
Sales Q2Q%3.85%
Revenue Next Year2.3%
Revenue Next 2Y3.44%
Revenue Next 3Y4.02%
Revenue Next 5Y3.81%
EBIT growth 1Y4.27%
EBIT growth 3Y4.18%
EBIT growth 5Y8.92%
EBIT Next Year5.85%
EBIT Next 3Y6.25%
EBIT Next 5Y7.26%
FCF growth 1Y-1.24%
FCF growth 3Y2.57%
FCF growth 5Y11.3%
OCF growth 1Y-1.81%
OCF growth 3Y2.14%
OCF growth 5Y9.92%